Outset Medical, Inc. OM Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 40.6%+1.5pp | 39.1%+1.4pp | 37.7%+1.2pp | 36.5%+0.5pp | 35.9%+2.0pp | |
| Operating margin | -57.2%-1.3pp | -55.8%+3.2pp | -59.1%+7.1pp | -66.2%+14.4pp | -80.6%+19.2pp | |
| Net margin | -63.7%+4.7pp | -68.3%+4.8pp | -73.1%+8.9pp | -82.1%+16.7pp | -98.7%+13.8pp | |
| EBITDA margin | -53.9%-1.7pp | -52.2%+2.8pp | -55%+6.8pp | -61.8%+13.9pp | -75.7%+19.0pp | |
| Free cash flow margin | -29.1%+10.3pp | -39.4%+5.5pp | -44.9%+12.4pp | -57.3%+26.6pp | -83.9%+19.2pp | |
| Returns | ||||||
| Return on equity | -53.2%+53.0pp | -106.2%-13.9pp | -92.3%-4.7pp | -87.7%-1.1pp | -86.5%+84.4pp | |
| Return on assets | -27.2%+3.0pp | -30.2%+0.6pp | -30.8%+1.7pp | -32.5%+2.7pp | -35.2%+8.3pp | |
| Return on invested capital | -35.9%+8.9pp | -44.8%-11.1pp | -33.7%+1.7pp | -35.4%+5.4pp | -40.8%+36.0pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Inventory turnover | 1.3×0.0× | 1.4×0.0× | 1.4×0.0× | 1.3×0.0× | 1.3×-0.1× | |
| Liquidity | ||||||
| Current ratio | 6.3×-0.4× | 6.7×-0.4× | 7.1×-0.4× | 7.5×-0.9× | 8.4×+2.7× | |
| Quick ratio | 5×-0.4× | 5.4×-0.4× | 5.8×-0.3× | 6.1×-0.7× | 6.7×+2.4× | |
| Cash ratio | 0.8×-0.1× | 0.9×0.0× | 1×-0.1× | 1.1×-1.1× | 2.2×-0.5× | |
| Leverage | ||||||
| Debt-to-equity | 0.9×+0.1× | 0.8×+0.1× | 0.7×+0.1× | 0.6×+0.1× | 0.6×-6.9× | |
| Debt-to-assets | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.3×0.0× | 0.3×-0.4× | |
| Interest coverage | -4.9×-0.1× | -4.8×-0.4× | -4.3×-0.2× | -4.2×+0.2× | -4.3×+0.4× | |
| Per Share | ||||||
| Book value per share | $6.08-27.2% | $8.35+4.3% | $8.01-8.2% | $8.72-63.9% | $24.14+212% | |
| Valuation | ||||||
| Market capitalization | $80.08M-77.6% | $67.35M-73.2% | $250.86M-29.1% | $353.91M+80.8% | $195.76M-31.9% | |
| Enterprise value | $151.13M-63.6% | $133.59M-57.3% | $313.1M-24.1% | $412.79M+89.4% | $218M-40.3% | |
| Price / sales | 0.7×-2.3× | 0.6×-1.5× | 2.1×-0.9× | 3×+1.3× | 1.7×-0.8× | |
| Price / book | 0.7×-1.6× | 0.5×-1.2× | 1.8×-0.5× | 2.3×+1.1× | 1.2×-9.6× | |
| EV / sales | 1.3×-2.2× | 1.1×-1.5× | 2.6×-0.9× | 3.5×+1.6× | 1.9×-1.3× | |
| Free cash flow yield | -42.8%-23.6pp | -70%-48.5pp | -21.5%-2.2pp | -19.3%+30.1pp | -49.4%-8.6pp | |
| Earnings yield | -93.5%-66.0pp | -121.2%-86.2pp | -35%-7.3pp | -27.7%+30.5pp | -58.1%-13.6pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Outset Medical, Inc.'s profit margins?
- Outset Medical, Inc. (OM) runs a 40.6% gross margin and a -57.2% operating margin, with a -63.7% net margin.
- Where do Outset Medical, Inc.'s ratios come from?
- Every ratio is computed from Outset Medical, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
